Clinical value of contrast-enhanced ultrasonography in differential diagnosis of hepatic epithelioid angiomyolipoma and hepatocellular carcinoma
返回论文页
|更新时间:2023-10-09
|
Clinical value of contrast-enhanced ultrasonography in differential diagnosis of hepatic epithelioid angiomyolipoma and hepatocellular carcinoma
Journal of Clinical Ultrasound in MedicineVol. 22, Issue 12, (2020)
作者机构:
1. 重庆医科大学附属第三医院捷尔医院 超声科
2. 成都新世纪妇女儿童医院影像科
作者简介:
基金信息:
DOI:
CLC:
Published:2020,
Published Online:31 December 2020,
扫 描 看 全 文
Clinical value of contrast-enhanced ultrasonography in differential diagnosis of hepatic epithelioid angiomyolipoma and hepatocellular carcinoma. [J]. Journal of Clinical Ultrasound in Medicine 22(12).(2020)
DOI:
Clinical value of contrast-enhanced ultrasonography in differential diagnosis of hepatic epithelioid angiomyolipoma and hepatocellular carcinoma. [J]. Journal of Clinical Ultrasound in Medicine 22(12).(2020)DOI:
Clinical value of contrast-enhanced ultrasonography in differential diagnosis of hepatic epithelioid angiomyolipoma and hepatocellular carcinoma
ABSRACT Objective To analyze the value of CEUS in differential diagnosis of liver epithelioid angiomyolipoma (EAML) and hepatocellular carcinoma. Methods The CEUS data of 40 patients with EAML and 40 patients with hepatocellular carcinoma were analyzed retrospectively. Qualitative and quantitative analysis of images was carried out with Qontrast software. The results of qualitative analysis included the degree of enhancement in different real-time enhancement periods. The results of quantitative analysis included the arrival time
peak intensity
peak time
enhancement slope and the start time of fading. Results Compared with the hepatocellular carcinoma group
the echo degree of EAML group was lower and the number of lesions was more (P<0.05). There was no significant difference between the two groups in the intensity of blood flow signal
the location of focus and the edge of focus (P > 0.05). Compared with hepatocellular carcinoma group
there were more cases of centripetal enhancement in EAML group
and the degree of delayed phase enhancement was lower (P < 0.05). There was no significant difference between the two groups in the enhancement degree of arterial phase and portal phase (P > 0.05). Compared with the hepatocellular carcinoma group
the peak intensity of EAML group was higher
while the peak time and the beginning time of regression were shorter (P < 0.05). There was no significant difference in enhancement slope and arrival time between the two groups (P > 0.05). Conclusion There are different blood perfusion characteristics between EAML and hepatocellular carcinoma. CEUS is valuable for the differential diagnosis of these two diseases.
Study on the differential diagnosis of renal cell carcinoma subtype and angiomyolipoma by contrast-enhanced ultrasound
Value Of Contrast-Enhanced Ultrasound Combined With C-TIRADS Classification In The Differential Diagnosis Of Thyroid Nodules
Evaluation on angiogenesis of esophageal transplanted tumor in nude mice by contrast-enhanced ultrasound time-intensity curves
The application value of contrast-enhanced ultrasound in predicting early therapeutic effect of concurrent chemoradiotherapy for locally advanced cervical cancer
Related Author
樊瑞琪
贾春梅
李廷廷
王婧婕
米娜
王卓然
wangkefeng
FU QIANG
Related Institution
Department of Ultrasound,First Hospital of Shanxi Medical University
河北省沧州市传染病医院功能科
Tel:?邮箱:@qqcom
黄冈市中心医院 超声医学科
Department of Abdominal Ultrasound, The Affiliated Hospital of Qingdao UniversityDepartment of Ultrasound,Linyi Tumor Hospital